Giron, P., Eggermont, C., Noeparast, A., Vandenplas, H., Teugels, E., Forsyth, R., . . . De Grève, J. (2021). Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer. Int J Cancer.
Citación estilo ChicagoGiron, Philippe, et al. "Targeting USP13‐mediated Drug Tolerance Increases the Efficacy of EGFR Inhibition of Mutant EGFR in Non‐small Cell Lung Cancer." Int J Cancer 2021.
Cita MLAGiron, Philippe, et al. "Targeting USP13‐mediated Drug Tolerance Increases the Efficacy of EGFR Inhibition of Mutant EGFR in Non‐small Cell Lung Cancer." Int J Cancer 2021.
Precaución: Estas citas no son 100% exactas.